NASDAQ:DARA (DARA) (DARA) Stock Price, News & Analysis → Little-known biotech company just had groundbreaking results from a study (From Smallcaps Daily) (Ad) Free DARA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range$0.32▼$0.3352-Week Range N/AVolume13,850 shsAverage Volume118,843 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (DARA) alerts: Email Address Ad Smallcaps DailyLittle-known biotech company just had groundbreaking results from a studyLearn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!Click here for the full report & ticker symbol About (DARA) Stock (NASDAQ:DARA)DARA BioSciences Inc is specialty pharmaceutical company based in the United States. The Company’s primary focus is on the commercialization of oncology treatment and oncology supportive care pharmaceutical products, including Soltamox, an oral solution of tamoxifen citrate; cancer support therapeutics, including Gelclair, indicated for the treatment of oral mucositis and Bionect, for the management of irritation of the skin as well as first and second degree burns, and Three Mission Pharmacal products, including Ferralet 90 (for anemia), Binosto (alendronate sodium effervescent tablet indicated for the treatment of osteoporosis) and Aquoral (for cancer related dry mouth). The Company has a clinical development asset, KRN5500, which is a Phase II product candidate targeted for treating cancer patients with painful treatment-refractory chronic chemotherapy induced peripheral neuropathy. The Company is a subsidiary of Midatech Pharma Plc.Read More Ad Smallcaps DailyLittle-known biotech company just had groundbreaking results from a studyLearn how this company could see tremendous growth ahead with a novel broad-spectrum antiviral that has activity against RSV!Click here for the full report & ticker symbol DARA Stock News HeadlinesMay 20 at 10:59 PM | msn.comDara Torres on Menopause Hormone Therapy: "I Feel Like I'm Myself Again"May 20 at 5:59 PM | msn.comHunter Schafer's Stylist Said the Cannes Headscarf Was Better Made Than Most of Her ClosetMay 19 at 3:53 PM | msn.comCommonwealth Global Ambassador Dara Sing Khurana talks about mental health | ABP LIVE InterviewMay 17, 2024 | msn.comKerry name Dara O’Callaghan at full back for All-Ireland Under-20 final against TyroneMay 17, 2024 | msn.comSandara Park, At 40 Years Old, Showcases Timeless Beauty in 2NE1’s Reunion PhotographsMay 16, 2024 | usnews.comDara KassMay 16, 2024 | msn.comDara Shikoh criticised Akbar’s Din-i-Ilahi, gave a combination of Vedanta & Tasawwuf insteadMay 13, 2024 | finance.yahoo.com5WPR Announces Executive Changes, Welcomes Michael O'Brien as Global CEOMay 12, 2024 | msn.comPWHL Draft Profile: Dara GreigMay 8, 2024 | msn.comUber Stock Endures $12 Billion Selloff On Nauseating Post-Earnings RideMay 8, 2024 | msn.comUber Technologies (UBER) Q1 2024 Earnings Call TranscriptMay 7, 2024 | msn.comVisually Impaired Man First In Kashmir Valley To Use Poll Panel’s Home Voting FacilityMay 6, 2024 | finance.yahoo.comDara Energy, a Production Focused Real Asset Company, Acquires Assets From Vinland Energy, an Appalachia Focused OperatorMay 5, 2024 | msn.comDara Solomon: Holocaust education is one answer to today's plague of antisemitismMay 4, 2024 | msn.comSandara Park jams to 'In or Out,' 'Festival' while touring Pagsanjan FallsMay 3, 2024 | markets.businessinsider.comEstée Lauder: Hold Rating Assigned Amid Slower Growth and Market PressuresMay 2, 2024 | msn.comIntroducing legislation that would restrict cell phone use in Pennsylvania schoolsMay 2, 2024 | yahoo.comPrincess Beatrice Is a Proud Mom as She Shares 2-Year-Old Daughter's Favorite HobbyMay 2, 2024 | msn.comSinton Trail opening on south side of Ellston StreetMay 2, 2024 | yahoo.comTruck theft suspect arrested after police chaseMay 2, 2024 | msn.comIn Florida, Kamala Harris puts spotlight on abortion politicsMay 1, 2024 | msn.comMaharashtra State Armwrestling Championship 2024: Dara Singh Handa reigns supremeMay 1, 2024 | yahoo.comFollowing an Honor Flight, a mission, and a life, completedMay 1, 2024 | markets.businessinsider.comEmploy Announces New Chief Product OfficerMay 1, 2024 | msn.comPueblo’s Team Up to Clean Up offering free dump daySee More Headlines Receive DARA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (DARA) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/02/2015Today5/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:DARA CUSIPN/A CIK919745 Webwww.darabiosciences.com Phone+1-816-9147027FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report DARA Stock Analysis - Frequently Asked Questions How were (DARA)'s earnings last quarter? (DARA) (NASDAQ:DARA) posted its quarterly earnings data on Monday, November, 2nd. The specialty pharmaceutical company reported ($0.14) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.14). The specialty pharmaceutical company had revenue of $1.18 million for the quarter, compared to analysts' expectations of $0.83 million. What other stocks do shareholders of (DARA) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (DARA) investors own include Castleton Technology (CTP), Richland Resources Ltd (RLD.L) (RLD), Thor Energy (THR), Global Invacom Group (GINV), Legendary Investments (LEG), iPass (IPAS), Aeterna Zentaris (AEZS), Clontarf Energy (CLON) and MoSys (MOSY). This page (NASDAQ:DARA) was last updated on 5/22/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryThe Presidential candidate you should REALLY be worried aboutStansberry ResearchThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarLittle-known biotech company just had groundbreaking results from a studySmallcaps DailyBill Clinton Backing Biden Replacement???The Freeport SocietyThe Crypto 9-5 Escape PlanCrypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsNew Options need New Trading StrategiesNetpicks Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (DARA) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.